Research Topics
| Mary E GaffieldSummaryAffiliation: World Health Organization Country: Switzerland Publications
| Collaborators
|
Detail Information
Publications
Medical eligibility criteria for new contraceptive methods: combined hormonal patch, combined hormonal vaginal ring and the etonogestrel implantMary E Gaffield
Department of Reproductive Health and Research, World Health Organization, CH 1211 Geneva 27, Switzerland
Contraception 73:134-44. 2006..Limited evidence also suggests no adverse effects of the etonogestrel implant on lactation parameters or infant development among users enrolled 28 to 56 days postpartum and followed for 4 months...
Use of combined oral contraceptives post abortionMary E Gaffield
Department of Reproductive Health and Research, World Health Organization, Geneva, 27, Switzerland
Contraception 80:355-62. 2009..Providing combined oral contraceptives (COCs) following surgical or medical induced abortion offers women an opportune moment to initiate a reliable contraceptive method...- Combined oral contraceptive and intrauterine device use among women with gestational trophoblastic diseaseMary E Gaffield
Department of Reproductive Health and Research, World Health Organization, 1211 Geneva 27, Switzerland
Contraception 80:363-71. 2009..Women diagnosed with gestational trophoblastic disease (GTD) need safe and effective contraception because they are advised to delay a subsequent pregnancy... - Oral contraceptives and family history of breast cancerMary E Gaffield
Department of Reproductive Health and Research, World Health Organization, 1211 Geneva 27, Switzerland
Contraception 80:372-80. 2009..Questions remain regarding whether oral contraceptive (OC) use among women with a family history of breast cancer increases disease risk... - The use of hormonal contraception among women taking anticonvulsant therapyMary E Gaffield
Department of Reproductive Health and Research, World Health Organization, 1211 Geneva, 27 Switzerland
Contraception 83:16-29. 2011..Drug interactions between hormonal contraceptives and anticonvulsants, resulting in reduced contraceptive effectiveness and/or increased seizure activity, have been published... - Initiation of progestogen-only injectables on different days of the menstrual cycle and its effect on contraceptive effectiveness and compliance: a systematic reviewNathalie Kapp
Department of Reproductive Health and Research, World Health Organization, Geneva CH 1211, Switzerland Electronic address
Contraception 87:576-82. 2013..Our objective was to determine from the literature when a woman can initiate progestogen-only injectables for contraception... - Risk of venous thromboembolism during the postpartum period: a systematic reviewEmily Jackson
Department of Reproductive Health and Research, World Health Organization, Geneva, Switzerland
Obstet Gynecol 117:691-703. 2011..To determine, from the literature, the risk of venous thromboembolism during the postpartum period... - Pregnancy outcomes with an IUD in situ: a systematic reviewDalia Brahmi
Department of Reproductive Health and Research, World Health Organization, CH 1211 Geneva 27, Switzerland
Contraception 85:131-9. 2012..The objective of this systematic review is to assess the evidence about risks for adverse pregnancy outcomes among women who conceive with an IUD in situ... - Effective use of hormonal contraceptives: Part II: Combined hormonal injectables, progestogen-only injectables and contraceptive implantsCamaryn E Chrisman
Wake Forest University School of Medicine, Winston-Salem, NC 27157, USA
Contraception 73:125-33. 2006..Norplant implants left in place for up to seven completed years remained effective among women who weighed <70 kg at the time of implant insertion, but their effectiveness decreased among women weighing >or=70 kg...